FDA Gains Cures Funding In Latest Draft
This article was originally published in The Pink Sheet Daily
Additional appropriations would be authorized for drug development tool qualification and manufacturing studies.
You may also be interested in...
House Democrats say FDA will need more money to be able to handle the responsibilities in the draft bill, while the agency worries reviews could slow without more resources.
The type of incentive remains under consideration, but one suggestion is a grading system similar to what restaurants receive from local health departments.
CDER-based program lead by Marta Sokolowska will also handle benzodiazepine and stimulants activities and consult on relevant application assessments.